» Articles » PMID: 34136483

Elevated Hydrostatic Pressure Causes Retinal Degeneration Through Upregulating Lipocalin-2

Overview
Specialty Cell Biology
Date 2021 Jun 17
PMID 34136483
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Elevation of intraocular pressure is a major risk factor for glaucoma development, which causes the loss of retinal ganglion cells (RGCs). Lipocalin 2 (Lcn2) is upregulated in glaucomatous retinae; however, whether Lcn2 is directly involved in glaucoma is debated. In this study, retinal explant cultures were subjected to increased water pressure using a two-chamber culture device, and Lcn2 protein levels were examined by immunoblotting. TdT-mediated dUTP nick and labeling (TUNEL) and glial fibrillary acidic protein (GFAP) immunohistochemical assays were performed to assess apoptosis and gliosis, respectively. The neurotoxicity of Lcn2 in the retinal explant culture was determined with exogenous administration of recombinant Lcn2. The Lcn2 protein levels, percentage of TUNEL-positive cells, and GFAP-positive area were significantly higher in retinae cultured under 50 cm HO pressure loads compared to those cultured under 20 cm HO. We found that Lcn2 exhibited neurotoxicity in retinae at dose of 1 μg/ml. The negative effects of increased hydrostatic pressure were attenuated by the iron chelator deferoxamine. This is the first report demonstrating the direct upregulation of Lcn2 by elevating hydrostatic pressure. Modulating Lcn2 and iron levels may be a promising therapeutic approach for retinal degeneration.

Citing Articles

Upregulation of lipocalin-2 in the retina of experimental autoimmune uveitis.

Kim H, Ahn M, Jung K, Hong S, Ko D, Kang T J Vet Med Sci. 2025; 87(3):301-307.

PMID: 39909419 PMC: 11903361. DOI: 10.1292/jvms.24-0231.


The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach.

Giuffrida E, Platania C, Lazzara F, Conti F, Marcantonio N, Drago F Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458974 PMC: 11509888. DOI: 10.3390/ph17101333.


An antibody-drug conjugate for endometrioid carcinoma based on the expression of cell adhesion molecule 1.

Hagiyama M, Yoneshige A, Otani T, Wada A, Takeuchi F, Shoya Y Mol Cell Oncol. 2024; 11(1):2399379.

PMID: 39252827 PMC: 11382700. DOI: 10.1080/23723556.2024.2399379.


Integrated Bioinformatics-Based Identification and Validation of Neuroinflammation-Related Hub Genes in Primary Open-Angle Glaucoma.

Ullah Z, Tao Y, Huang J Int J Mol Sci. 2024; 25(15).

PMID: 39125762 PMC: 11311784. DOI: 10.3390/ijms25158193.


Differential Retinal Ganglion Cell Vulnerability, A Critical Clue for the Identification of Neuroprotective Genes in Glaucoma.

Amin D, Kuwajima T Front Ophthalmol (Lausanne). 2024; 2:905352.

PMID: 38983528 PMC: 11182220. DOI: 10.3389/fopht.2022.905352.


References
1.
Yasuda M, Tanaka Y, Omodaka K, Nishiguchi K, Nakamura O, Tsuda S . Transcriptome profiling of the rat retina after optic nerve transection. Sci Rep. 2016; 6:28736. PMC: 4926057. DOI: 10.1038/srep28736. View

2.
Hagiyama M, Yabuta N, Okuzaki D, Inoue T, Takashima Y, Kimura R . Modest Static Pressure Suppresses Columnar Epithelial Cell Growth in Association with Cell Shape and Cytoskeletal Modifications. Front Physiol. 2017; 8:997. PMC: 5723396. DOI: 10.3389/fphys.2017.00997. View

3.
Libby R, Anderson M, Pang I, Robinson Z, Savinova O, Cosma I . Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci. 2005; 22(5):637-48. DOI: 10.1017/S0952523805225130. View

4.
Lee S, Park J, Lee W, Kim H, Park H, Mori K . Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci. 2009; 29(1):234-49. PMC: 6664907. DOI: 10.1523/JNEUROSCI.5273-08.2009. View

5.
Fischer R, Risner M, Roux A, Wareham L, Sappington R . Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma. Front Neurosci. 2019; 13:1139. PMC: 6838637. DOI: 10.3389/fnins.2019.01139. View